Literature DB >> 2116784

Role of apolipoprotein levels in clinical practice.

S M Grundy1, G L Vega.   

Abstract

Mesh：

Substances：

Year:  1990        PMID： 2116784

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  6 in total

1.  Drug treatment of hypercholesterolaemia. Establish diagnosis before treatment.

Authors:  M D Feher; A S Wierzbicki; T M Reynolds
Journal:  BMJ       Date:  1994-01-01

2.  Differentially expressed urinary biomarkers in children with idiopathic nephrotic syndrome.

Authors:  C P Suresh; Abhijeet Saha; Manpreet Kaur; Ritesh Kumar; N K Dubey; Trayambak Basak; Vinay Singh Tanwar; Gaurav Bhardwaj; Shantanu Sengupta; Vineeta Vijay Batra; Ashish Datt Upadhyay
Journal:  Clin Exp Nephrol       Date:  2015-09-09       Impact factor: 2.801

3.  Lipid and apolipoprotein levels during therapy with pinacidil combined with hydrochlorothiazide.

Authors:  C N Corder; M R Goldberg; P A Alaupovic; M D Price; S S Furste
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

4.  Development of multiplexed bead-based immunoassays for the detection of early stage ovarian cancer using a combination of serum biomarkers.

Authors:  Yong-Wan Kim; Su Mi Bae; Hyunsun Lim; Yoon Ji Kim; Woong Shick Ahn
Journal:  PLoS One       Date:  2012-09-10       Impact factor: 3.240

5.  Identification of Apo-A1 as a biomarker for early diagnosis of bladder transitional cell carcinoma.

Authors:  Hongjie Li; Changying Li; Huili Wu; Ting Zhang; Jin Wang; Shixin Wang; Jiwu Chang
Journal:  Proteome Sci       Date:  2011-04-17       Impact factor: 2.480

6.  Proteomics approaches for identification of tumor relevant protein targets in pulmonary squamous cell carcinoma by 2D-DIGE-MS.

Authors:  Hao Lihong; Gong Linlin; Guo Yiping; Song Yang; Qi Xiaoyu; Guan Zhuzhu; Yang Xiaohan; Zhou Xin; Xue Liyan; Shao Shujuan
Journal:  PLoS One       Date:  2014-04-16       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.